CRISPR Gene Activation Reduces Seizures and Aggression in Mouse Model of Rare Epileptic Disorder
Researchers used a CRISPR-based transcriptional activation system to restore normal Stxbp1 gene expression in haploinsufficient mice, reducing seizure frequency by approximately 50% and partially attenuating aggressive behavior. STXBP1 mutations cause severe epileptic encephalopathies such as Ohtahara syndrome, for which no curative treatment currently exists, and the disease is driven by insufficient protein production from a single functional gene copy. The findings suggest that activating the endogenous wild-type allele — rather than replacing or editing the mutant one — could serve as a broadly applicable therapeutic platform for haploinsufficiency disorders.
A study posted to bioRxiv demonstrates that CRISPR-mediated transcriptional activation (CRISPR-ON), using a dCas9-VPR system guided by a multiplexed four-gRNA cassette, can restore Stxbp1 mRNA and Munc18-1 protein levels to wild-type ranges in a mouse model of STXBP1 haploinsufficiency. The STXBP1 gene encodes the presynaptic protein Munc18-1, and loss-of-function mutations in one allele cause a spectrum of severe neurodevelopmental and epileptic encephalopathies, including Ohtahara syndrome. AAV-PHP.eB vectors carrying the gRNA cassette and Cre recombinase were delivered intracerebroventricularly to neonatal mice harboring a conditional dCas9-VPR allele, enabling brain-wide transcriptional upregulation of the intact Stxbp1 allele. Electrocorticographic recordings showed roughly a 50% reduction in spike-wave discharge frequency in treated animals compared to untreated haploinsufficient controls, and aggressive behavior in a resident-intruder assay was also partially reduced. Importantly, locomotor activity was unaffected, indicating phenotype-selective rescue without motor side effects. The authors argue these results support endogenous gene activation as a generalizable strategy for other haploinsufficiency-driven neurological disorders.
What's missing
As a preprint, this study has not yet undergone peer review. Key limitations include reliance on a mouse model that may not fully recapitulate human STXBP1 encephalopathy, the use of a conditional transgenic dCas9-VPR allele rather than a fully exogenous delivery system (limiting direct clinical translatability), and the absence of long-term safety and efficacy data. The study does not address whether the degree of seizure reduction observed would be clinically meaningful in human patients.
What different sources said
- bioRxivCenter
4 Phenylbutyrate Plus Gene augmentation: A dual therapy To Rescue of SLC6A1 Variant Associated Developmental And Epileptic Encephalopathy
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.